The Cannabis Policy Scale: A New Research and Surveillance Tool for U.S. States.
Journal
Journal of studies on alcohol and drugs
ISSN: 1938-4114
Titre abrégé: J Stud Alcohol Drugs
Pays: United States
ID NLM: 101295847
Informations de publication
Date de publication:
11 2022
11 2022
Historique:
entrez:
9
12
2022
pubmed:
10
12
2022
medline:
15
12
2022
Statut:
ppublish
Résumé
Rapid shifts toward cannabis liberalization in the United States have created immense policy variability that is challenging to measure. We developed composite measures to characterize the restrictiveness of U.S. state cannabis policy environments. Nine panelists, consisting of four research team members and five expert policy consultants, nominated distinct cannabis policies pertaining to cannabis prohibition, medicalization, and legalization for recreational use. For each of the 17 nominated policies, panelists developed implementation ratings and rated each policy's relative efficacy for reducing excessive cannabis use by adults, youth use, and impaired driving. Cannabis Policy Scale scores were then calculated for each state-year for all 50 states from 1999 to 2019 by weighting policies by their efficacy and implementation ratings, and then summing over policies. Median Cannabis Policy Scale scores remained stable until 2008, when they started declining (representing policy liberalization), with steeper declines after 2012. In 2019, state Cannabis Policy Scale scores targeting excessive use among the general population ranged from 29.6 to 66.7 for recreational cannabis legalization states, and from 72.4 to 93.4 for medical cannabis legalization states. Cannabis Policy Scale scores using youth-specific and driving-specific efficacy ratings showed similar trends. The Cannabis Policy Scale reflects trends toward liberalization of cannabis policy in many U.S. states. Even within crude policy phenotypes (e.g., medical cannabis programs), Cannabis Policy Scale scores varied considerably between states and over time. The Cannabis Policy Scale is a new measure that can add nuance to cannabis policy research and help assess cannabis policy-outcome relationships.
Identifiants
pubmed: 36484580
pmc: PMC9756403
doi: 10.15288/jsad.21-00462
doi:
Substances chimiques
Medical Marijuana
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
829-838Subventions
Organisme : NIAAA NIH HHS
ID : R01 AA026268
Pays : United States
Déclaration de conflit d'intérêts
The authors have no conflicts of interest to declare.
Références
Subst Use Misuse. 2016 Jul 28;51(9):1174-84
pubmed: 27191472
Health Aff (Millwood). 2016 Mar;35(3):480-8
pubmed: 26953303
Pediatrics. 2017 Mar;139(3):
pubmed: 28193794
Tob Control. 2019 Jan;28(1):101-109
pubmed: 29472445
Int J Drug Policy. 2009 Nov;20(6):475-9
pubmed: 19356915
Am J Prev Med. 2020 May;58(5):622-629
pubmed: 32192802
JAMA Intern Med. 2018 Jul 1;178(7):894-901
pubmed: 29813162
Tob Control. 2006 Jun;15(3):247-53
pubmed: 16728757
Addiction. 2017 Jul;112(7):1128-1135
pubmed: 27891693
Int J Drug Policy. 2021 Aug;94:103202
pubmed: 33765514
PLoS Med. 2007 Apr;4(4):e153
pubmed: 17455993
BMC Public Health. 2021 Mar 1;21(1):366
pubmed: 33641667
Prev Chronic Dis. 2015 Oct 15;12:E177
pubmed: 26469950
Alcohol Clin Exp Res. 2016 Dec;40(12):2614-2621
pubmed: 27676334
Int J Drug Policy. 2010 Jan;21(1):64-9
pubmed: 19303761
Am J Drug Alcohol Abuse. 2019;45(6):644-663
pubmed: 31603710
Rev Panam Salud Publica. 2018;42:
pubmed: 29937675
Am J Prev Med. 2014 Jan;46(1):10-6
pubmed: 24355666
Am J Prev Med. 2019 Aug;57(2):172-179
pubmed: 31239088
Tob Induc Dis. 2020 Nov 03;18:91
pubmed: 33192223
PLoS Med. 2007 Apr;4(4):e151
pubmed: 17455992
Addiction. 2009 Nov;104(11):1918-26
pubmed: 19663897
J Policy Anal Manage. 2015 Winter;34(1):7-31
pubmed: 25558490
Annu Rev Clin Psychol. 2017 May 8;13:397-419
pubmed: 28482686